As stem cell derived models of human liver biology move closer to diagnostic implementation there is an imperative for model standardisation living up to requirements of regulators and pharma industry’s needs.Reading time: 6 minRead more ...
B2Bioworld offers you background information
Ruth McKernan, CSO Pfizer Regenerative Medicine on the beginnings and competitors
Kurt Stoeckli, Global Head of Biological Sciences / Discovery Sanofi Aventis
Sir Patrick Vallance, at the time President Pharmaceuticals, R&D of GlaxoSmithKline